H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Bi… — Informed

Committee MeetingHouseMarkup

H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Biosimilars Act”; H.R. 2374, the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act”; and H.R. 2376, the “Prescription Pricing for People Act of 2019”.

Held

Tuesday, April 30, 2019

Rayburn House Office Building 2141

Held by

House Judiciary

Watch / read on Congress.gov

H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Bi… — Informed